Skystar Bio-Pharmaceutical Co (Skystar Bio-Pharmaceutical Co) Other Net Income (Loss) : $-0.00 Mil (TTM As of Sep. 2014)

View and export this data going back to . Start your Free Trial

What is Skystar Bio-Pharmaceutical Co Other Net Income (Loss)?

Skystar Bio-Pharmaceutical Co's Other Net Income (Loss) for the three months ended in Sep. 2014 was $0.00 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Sep. 2014 was $-0.00 Mil.

Skystar Bio-Pharmaceutical Co's quarterly Other Net Income (Loss) increased from Mar. 2014 ($-0.00 Mil) to Jun. 2014 ($0.00 Mil) but then stayed the same from Jun. 2014 ($0.00 Mil) to Sep. 2014 ($0.00 Mil).

Skystar Bio-Pharmaceutical Co's annual Other Net Income (Loss) declined from Dec. 2011 ($0.00 Mil) to Dec. 2012 ($-0.00 Mil) and declined from Dec. 2012 ($-0.00 Mil) to Dec. 2013 ($-0.00 Mil).

Skystar Bio-Pharmaceutical Co Other Net Income (Loss) Historical Data

The historical data trend for Skystar Bio-Pharmaceutical Co's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Skystar Bio-Pharmaceutical Co Other Net Income (Loss) Chart

Skystar Bio-Pharmaceutical Co Annual Data

Trend

Dec04

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Other Net Income (Loss)

Get a 7-Day Free Trial

Skystar Bio-Pharmaceutical Co Quarterly Data
	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14
Other Net Income (Loss)	Get a 7-Day Free Trial															-	-	-	-	-

Skystar Bio-Pharmaceutical Co Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Sep. 2014 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.00 Mil.

Skystar Bio-Pharmaceutical Co Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Skystar Bio-Pharmaceutical Co's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Skystar Bio-Pharmaceutical Co (Skystar Bio-Pharmaceutical Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Skystar Bio-Pharmaceutical Co (GREY:SKBI) » Definitions » Other Net Income (Loss)

Traded in Other Exchanges

N/A

Address

No. 48 Keji Road, 4/F Building B, Chuangye Square, Gaoxin District, Xian, Shaanxi Province, CHN

Website

http://www.skystarbio-pharmaceutical.com

Skystar Bio-Pharmaceutical Co is a holding company. Through its subsidiaries, it is engaged in the research, development, production, marketing, and sales of veterinary healthcare and medical care products in the People's Republic of China. The company provides individually packaged animal wellness and pharmaceutical products for retail sale. It generates revenue from the sales of four product lines namely, veterinary medications, micro-organism, feed additives, and vaccines. The firm develops, manufactures, packages and distributes vaccines; Western medicines, Traditional Chinese Medicine; topicals, supplements, probiotics; diagnostic kits and animal nutrition supplements for poultry, livestock, marine aquaculture and domesticated pets.

Skystar Bio-Pharmaceutical Co (Skystar Bio-Pharmaceutical Co) Headlines

No Headlines